AtriCure Statistics
Share Statistics
AtriCure has 48.75M shares outstanding. The number of shares has increased by 2.85% in one year.
| Shares Outstanding | 48.75M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.65% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 47.17M |
| Failed to Deliver (FTD) Shares | 1.14K |
| FTD / Avg. Volume | 0.21% |
Short Selling Information
The latest short interest is 2.25M, so 4.61% of the outstanding shares have been sold short.
| Short Interest | 2.25M |
| Short % of Shares Out | 4.61% |
| Short % of Float | 4.77% |
| Short Ratio (days to cover) | 3.86 |
Valuation Ratios
The PE ratio is -54.3 and the forward PE ratio is -58.14.
| PE Ratio | -54.3 |
| Forward PE | -58.14 |
| PS Ratio | 4.14 |
| Forward PS | 3 |
| PB Ratio | 3.55 |
| P/FCF Ratio | -44.06 |
| PEG Ratio | n/a |
Enterprise Valuation
AtriCure Inc. has an Enterprise Value (EV) of 1.73B.
| EV / Earnings | -56.75 |
| EV / Sales | 4.33 |
| EV / EBITDA | -213.01 |
| EV / EBIT | -64.73 |
| EV / FCF | -46.04 |
Financial Position
The company has a current ratio of 3.57, with a Debt / Equity ratio of 0.14.
| Current Ratio | 3.57 |
| Quick Ratio | 2.66 |
| Debt / Equity | 0.14 |
| Total Debt / Capitalization | 11.93 |
| Cash Flow / Debt | 0.07 |
| Interest Coverage | -3.85 |
Financial Efficiency
Return on equity (ROE) is -0.07% and return on capital (ROIC) is -5.03%.
| Return on Equity (ROE) | -0.07% |
| Return on Assets (ROA) | -0.05% |
| Return on Capital (ROIC) | -5.03% |
| Revenue Per Employee | 332.70K |
| Profits Per Employee | -25.36K |
| Employee Count | 1.20K |
| Asset Turnover | 0.65 |
| Inventory Turnover | 1.46 |
Taxes
| Income Tax | 591.00K |
| Effective Tax Rate | -0.02 |
Stock Price Statistics
The stock price has increased by -11.69% in the last 52 weeks. The beta is 1.41, so AtriCure 's price volatility has been higher than the market average.
| Beta | 1.41 |
| 52-Week Price Change | -11.69% |
| 50-Day Moving Average | 32.68 |
| 200-Day Moving Average | 27.09 |
| Relative Strength Index (RSI) | 39.81 |
| Average Volume (20 Days) | 535.55K |
Income Statement
In the last 12 months, AtriCure had revenue of $399.25M and earned -$30.44M in profits. Earnings per share was $-0.66.
| Revenue | 399.25M |
| Gross Profit | 300.37M |
| Operating Income | -26.68M |
| Net Income | -30.44M |
| EBITDA | -8.11M |
| EBIT | -26.68M |
| Earnings Per Share (EPS) | -0.66 |
Balance Sheet
The company has $84.31M in cash and $74.49M in debt, giving a net cash position of $9.82M.
| Cash & Cash Equivalents | 84.31M |
| Total Debt | 74.49M |
| Net Cash | 9.82M |
| Retained Earnings | -357.06M |
| Total Assets | 615.07M |
| Working Capital | 194.85M |
Cash Flow
In the last 12 months, operating cash flow was $4.48M and capital expenditures -$42.00M, giving a free cash flow of -$37.51M.
| Operating Cash Flow | 4.48M |
| Capital Expenditures | -42.00M |
| Free Cash Flow | -37.51M |
| FCF Per Share | -0.81 |
Margins
Gross margin is 75.23%, with operating and profit margins of -6.68% and -7.62%.
| Gross Margin | 75.23% |
| Operating Margin | -6.68% |
| Pretax Margin | -7.48% |
| Profit Margin | -7.62% |
| EBITDA Margin | -2.03% |
| EBIT Margin | -6.68% |
| FCF Margin | -9.4% |
Dividends & Yields
ATRC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -2.1% |
| FCF Yield | -2.44% |
Analyst Forecast
The average price target for ATRC is $40, which is 27% higher than the current price. The consensus rating is "Buy".
| Price Target | $40 |
| Price Target Difference | 27% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
Scores
| Altman Z-Score | 6.45 |
| Piotroski F-Score | 4 |